BullFrog AI Holdings BFRG
NASDAQ BFRG
$0.50 +0.01 (+2.04%)
At close: Sep 4, 2026 · 4:00 PM EDT

BullFrog AI Holdings (BFRG) Notes Payables (2021 - 2025)

BullFrog AI Holdings' (BFRG) quarterly Notes Payables came in at $55606.0 in Q3 2025, down 67.67% on a YoY basis from $172005.0 in Q3 2024, and down 49.58% quarter-over-quarter from $110291.0 in Q2 2025.

Analysis

BullFrog AI Holdings (BFRG) Notes Payables (2021 - 2025) Analysis & Trends

BullFrog AI Holdings (BFRG) has reported Notes Payables for 5 consecutive years, with $55606.0 the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables fell 67.67% year-over-year to $55606.0; the trailing twelve-month figure through Sep 2025 stood at $55606.0 (down 67.67% YoY), and the FY2022 full-year result was $254850.0, up 420.1% from the prior year.
  • Notes Payables eased to $55606.0 in Q3 2025 per BFRG's latest filing, from $110291.0 in the prior quarter.
  • Across five years, Notes Payables topped out at $629486.0 in Q1 2023 and bottomed at $49000.0 in Q4 2021.
  • Historically, Notes Payables has averaged $265440.3 across 5 years, with a median of $213290.0 in 2023.
  • The sharpest annual moves came in 2022 and 2025: Notes Payables soared 420.1% in 2022, then slumped 67.67% in 2025.
  • Over 5 years, Notes Payables stood at $49000.0 in 2021, then jumped by 420.1% to $254850.0 in 2022, then dropped by 16.31% to $213290.0 in 2023, then declined by 19.36% to $172005.0 in 2024, then plunged by 67.67% to $55606.0 in 2025.
  • According to Business Quant data, Notes Payables over the past three periods registered $55606.0, $110291.0, and $164070.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BullFrog AI Holdings 9.27 Mn 2.35 Mn 106,899.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 55,606.00
Jun 30, 2025 110,291.00
Mar 31, 2025 164,070.00
Sep 30, 2024 172,005.00
Jun 30, 2024 341,040.00
Mar 31, 2024 507,154.00
Sep 30, 2023 213,290.00
Jun 30, 2023 423,051.00
Mar 31, 2023 629,486.00
Dec 31, 2022 254,850.00
Dec 31, 2021 49,000.00